Oncotelic Bets Big on AI Compliance Tech

Oncotelic Therapeutics Inc. (OTCQB: OTLC) has announced its placement in an editorial by AINewsWire, highlighting the company's growing position in the AI-driven automated compliance space. The editorial was published through AINewsWire, one of over 75 brands within the Dynamic Brand Portfolio at InvestorBrandNetwork, a communications platform focused on financial news and content distribution for public and private companies.